Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| INTZ | INTRUSION INC | United States | $3.15M | 1,944,675 | 8.92% | 91.08% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.87M | 439,926,480 | 0.79% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $10.51M | 198,386,080 | 1.23% | 0.00% | ||
| IQ | IQIYI INC | China | $4.88B | 6,716,137,085 | 4.53% | 0.00% | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $7.00M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| LIFE | ATYR PHARMA INC | United States | $111.11M | 69,010,940 | 59.74% | 22.13% | Net Buying | Net Selling |
| BPTH | BIO-PATH HOLDINGS INC | United States | $1.77M | 678,795 | 3.24% | 96.76% | ||
| BIOL | BIOLASE INC | United States | $4.72M | 32,522,593 | 0.92% | 56.96% | ||
| GOEV | CANOO INC | United States | $178.38M | 64,397,326 | 44.63% | 55.37% | Net Buying | Net Selling |
| APLM | APOLLOMICS INC | United States | $35.53M | 89,495,790 | 9.89% | 0.00% | ||
| CLNN | CLENE INC | United States | $55.87M | 128,430,098 | 9.06% | 52.69% | Net Buying | Net Selling |
| KZR | KEZAR LIFE SCIENCES INC | United States | $62.39M | 72,801,359 | 67.83% | 21.82% | Net Buying | |
| APTO | APTOSE BIOSCIENCES INC | Canada | $18.86M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $56.38M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $11.64M | 53,156,369 | 22.27% | 77.73% | Net Selling | |
| MVST | MICROVAST HOLDINGS INC | United States | $122.12M | 317,206,095 | 20.63% | 31.20% | Net Selling | |
| GOSS | GOSSAMER BIO INC | United States | $166.93M | 225,582,250 | 86.47% | 13.53% | Net Buying | Net Selling |
| OCUP | OCUPHIRE PHARMA INC | United States | $49.38M | 24,813,370 | 1.23% | 98.77% | Net Buying | Net Buying |
| AGEN | AGENUS INC | United States | $273.76M | 20,946,004 | 63.15% | 36.85% | Net Buying | Net Buying |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.71M | 3,069,516 | 1.86% | 98.14% | Net Buying | |
| AADI | AADI BIOSCIENCE INC | United States | $52.05M | 24,554,205 | 26.93% | 73.07% | Net Selling | Net Selling |
| YTEN | YIELD10 BIOSCIENCE INC | United States | $3.59M | 641,738 | 2.09% | 97.91% | Net Buying | Net Buying |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $31.81M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| TARA | PROTARA THERAPEUTICS INC | United States | $59.92M | 20,589,976 | 11.95% | 88.05% | Net Selling | |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $89.82M | 53,149,778 | 33.44% | 24.16% | ||
| INAB | IN8BIO INC | United States | $43.29M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| EVA | ENVIVA INC | United States | $37.99M | 74,496,537 | 27.69% | 72.31% | Net Selling | Net Selling |
| FEMY | FEMASYS INC | United States | $28.51M | 22,099,347 | 6.42% | 8.05% | ||
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $82.51M | 54,642,580 | 81.93% | 18.07% | Net Buying | Net Buying |
| GEVO | GEVO INC | United States | $155.91M | 236,232,717 | 35.74% | 11.14% | Net Selling | |
| SYBX | SYNLOGIC INC | United States | $21.43M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| NTBL | NOTABLE LABS LTD | Israel | $8.57M | 9,018,261 | 2.63% | 97.37% | Net Selling | |
| LUXH | LUXURBAN HOTELS INC | United States | $35.12M | 41,814,361 | 7.28% | 85.94% | Net Buying | |
| IMRX | IMMUNEERING CORP | United States | $48.02M | 29,283,272 | 53.75% | 46.25% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $102.89M | 26,865,473 | 21.54% | 5.21% | Net Selling | Net Selling |
| ACET | ADICET BIO INC | United States | $119.12M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| PRST | PRESTO AUTOMATION INC | United States | $13.73M | 80,791,967 | 8.56% | 68.69% | Net Buying | |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $137.87M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| VOR | VOR BIOPHARMA INC | United States | $122.70M | 68,168,771 | 87.43% | 10.18% | Net Selling | Net Selling |
| LUMO | LUMOS PHARMA INC | United States | $24.00M | 8,107,121 | 17.70% | 82.30% | Net Buying | Net Buying |
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.21% | 0.00% | ||
| SPRB | SPRUCE BIOSCIENCES INC | United States | $30.61M | 41,149,160 | 63.59% | 36.41% | Net Selling | Net Selling |
| PASG | PASSAGE BIO INC | United States | $72.83M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
| IKNA | IKENA ONCOLOGY INC | United States | $63.70M | 48,258,111 | 66.60% | 18.22% | ||
| CVKD | CADRENAL THERAPEUTICS INC | United States | $7.84M | 16,008,469 | 3.45% | 46.72% | Net Buying | |
| FBIO | FORTRESS BIOTECH INC | United States | $33.66M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| PGEN | PRECIGEN INC | United States | $353.47M | 248,919,096 | 25.15% | 73.45% | Net Buying | Net Selling |
| MBRX | MOLECULIN BIOTECH INC | United States | $11.18M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $81.89M | 22,192,026 | 4.15% | 95.85% | ||
| IVA | INVENTIVA SA | France | $171.98M | 52,115,807 | 9.33% | 0.00% | ||
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $547.86M | 64,227,371 | 35.78% | 53.62% | Net Selling | Net Selling |
| AQMS | AQUA METALS INC | United States | $52.39M | 111,953,875 | 17.59% | 15.42% | Net Selling | |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $150.77M | 202,645,716 | 46.82% | 14.34% | Net Selling | Net Buying |
| GRTS | GRITSTONE BIO INC | United States | $94.44M | 98,065,594 | 42.92% | 22.25% | Net Buying | |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $111.91M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| LCTX | LINEAGE CELL THERAPEUTICS INC | United States | $199.85M | 188,533,536 | 34.36% | 65.64% | Net Buying | Net Buying |
| LQR | LQR HOUSE INC | United States | $4.68M | 4,829,438 | 0.21% | 38.07% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.